Sergio Fazio

Professor

  • 14191 Citations
  • 62 h-Index
1979 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Apolipoproteins E Medicine & Life Sciences
Atherosclerosis Medicine & Life Sciences
Macrophages Medicine & Life Sciences
Cholesterol Medicine & Life Sciences
LDL Receptors Medicine & Life Sciences
Lipoproteins Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
Lipids Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1979 2021

Lipoproteins
LDL Receptors
Furin
Proprotein Convertase 9
LDL Cholesterol

RESEARCH AND DEVELOPMENT PROGRAM

Fazio, S., Cherrington, A., Hanley, G. A., Granner, D., Vaughan, D. E., Salleng, K., McGuinness, O., Wasserman, D. & Vaughan, D. E.

National Institutes of Health

3/1/016/30/21

Project: Research project

research and development
Pathology
director
technical innovation
Research
HDL Lipoproteins
Cholesterol
Research Personnel
Lipoproteins
Macrophages
Lipoprotein Receptors
LDL Receptors
Atherosclerosis
Cholesterol
Proprotein Convertase 9
Atherosclerosis
Macrophages
Cholesterol
Foam Cells
Blood Vessels

Research Output 1982 2019

3 Citations (Scopus)

Application of PCSK9 Inhibitors in Practice

Kaufman, T., Warden, B. A., Minnier, J., Miles, J. R., Duell, P., Purnell, J., Wojcik, C., Fazio, S. & Shapiro, M., Jan 4 2019, In : Circulation Research. 124, 1, p. 32-37 6 p.

Research output: Contribution to journalArticle

Subtilisin
Proteins
Insurance
Therapeutics
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1 Citation (Scopus)

Brief commentary: Marijuana and cardiovascular disease—what should we tell patients?

Kaufman, T., Fazio, S. & Shapiro, M., Jan 15 2019, In : Annals of Internal Medicine. 170, 2, p. 119-120 2 p.

Research output: Contribution to journalComment/debate

Cannabis
Cardiovascular Diseases
9 Citations (Scopus)

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk

O'Donoghue, M. L., Fazio, S., Giugliano, R. P., Stroes, E. S. G., Kanevsky, E., Gouni-Berthold, I., Im, K. A., Lira Pineda, A., Wasserman, S. M., Češka, R., Ezhov, M. V., Jukema, J. W., Jensen, H. K., Tokgözoğlu, S. L., Mach, F., Huber, K., Sever, P. S., Keech, A. C., Pedersen, T. R. & Sabatine, M. S., Mar 19 2019, In : Circulation. 139, 12, p. 1483-1492 10 p.

Research output: Contribution to journalArticle

Proprotein Convertases
Subtilisin
Lipoprotein(a)
LDL Cholesterol
Numbers Needed To Treat
1 Citation (Scopus)

Overview of Therapeutic Approaches for Cholesterol Lowering and Attenuation of Thrombosis for Prevention of Atherothrombosis

Weitz, J. I. & Fazio, S., Feb 1 2019, In : Circulation Research. 124, 3, p. 351-353 3 p.

Research output: Contribution to journalEditorial

Plasminogen
Fibrinogen
Thrombosis
Collagen
Cholesterol
2 Citations (Scopus)
Open Access
Lipoprotein(a)
LDL Lipoproteins
LDL Cholesterol
Clinical Trials
Hydroxymethylglutaryl-CoA Reductase Inhibitors